28180050|t|Utility of an Ultrasonic Aspirator in Transcanal Endoscopic Resection of Temporal Bone Paraganglioma
28180050|a|The objective of this study was to evaluate the role of removing middle ear paragangliomas using an ultrasonic aspirator (UA) through a transcanal, exclusively endoscopic approach. Three consecutive patients undergoing transcanal endoscopic resection of middle ear paragangliomas using an UA were retrospectively studied. The primary outcome measure was achieving gross total tumor resection. Secondary outcomes included postoperative hearing and early convalescence. Two glomus tympanicum tumors and one small glomus jugulare were included, and complete tumor resection was achieved endoscopically in all cases. All patients demonstrated intact tympanic membranes and normal facial nerve function at the initial postoperative visit. There were no cases of bone-conduction pure tone threshold increases of more than 15 dB. The UA was helpful when performing exclusively endoscopic transcanal resection of middle ear paraganglioma given its simultaneous suction-aspiration capability.
28180050	14	34	Ultrasonic Aspirator	T074	C0179167
28180050	38	69	Transcanal Endoscopic Resection	T061	C0728940
28180050	73	86	Temporal Bone	T023	C0039484
28180050	87	100	Paraganglioma	T191	C0030421
28180050	105	114	objective	T170	C0018017
28180050	123	128	study	T062	C0008972
28180050	136	144	evaluate	T058	C0220825
28180050	157	165	removing	T061	C0728940
28180050	166	191	middle ear paragangliomas	T191	C1334761
28180050	201	221	ultrasonic aspirator	T074	C0179167
28180050	223	225	UA	T074	C0179167
28180050	237	247	transcanal	T082	C1254362
28180050	261	280	endoscopic approach	T082	C0442418
28180050	288	299	consecutive	T080	C1707491
28180050	300	308	patients	T101	C0030705
28180050	320	351	transcanal endoscopic resection	T061	C0728940
28180050	355	380	middle ear paragangliomas	T191	C1334761
28180050	390	392	UA	T074	C0179167
28180050	398	421	retrospectively studied	T062	C0035363
28180050	427	450	primary outcome measure	T080	C3274433
28180050	465	492	gross total tumor resection	T061	C0728940
28180050	494	512	Secondary outcomes	T080	C3274440
28180050	522	535	postoperative	T033	C0231287
28180050	536	543	hearing	T039	C0018767
28180050	548	553	early	T079	C1279919
28180050	554	567	convalescence	T033	C0009940
28180050	573	597	glomus tympanicum tumors	T191	C0474820
28180050	606	611	small	T081	C0700321
28180050	612	627	glomus jugulare	T191	C0017671
28180050	633	641	included	T169	C0332257
28180050	647	655	complete	T080	C0205197
28180050	656	661	tumor	T191	C0027651
28180050	662	671	resection	T061	C0728940
28180050	685	699	endoscopically	T060	C0014245
28180050	707	712	cases	T077	C1706256
28180050	718	726	patients	T101	C0030705
28180050	740	746	intact	T080	C0205266
28180050	747	765	tympanic membranes	T023	C0041445
28180050	770	776	normal	T080	C0205307
28180050	777	789	facial nerve	T023	C0015462
28180050	790	798	function	T042	C1254358
28180050	806	813	initial	T079	C0205265
28180050	814	833	postoperative visit	T033	C0580703
28180050	849	854	cases	T077	C1706256
28180050	858	893	bone-conduction pure tone threshold	T081	C0004312
28180050	894	903	increases	T081	C0205217
28180050	928	930	UA	T074	C0179167
28180050	948	958	performing	T061	C0450010
28180050	971	1002	endoscopic transcanal resection	T061	C0728940
28180050	1006	1030	middle ear paraganglioma	T191	C1334761
28180050	1041	1053	simultaneous	T079	C0521115
28180050	1054	1083	suction-aspiration capability	T080	C2698977